全文获取类型
收费全文 | 251982篇 |
免费 | 19822篇 |
国内免费 | 4376篇 |
专业分类
耳鼻咽喉 | 3431篇 |
儿科学 | 5144篇 |
妇产科学 | 4206篇 |
基础医学 | 19311篇 |
口腔科学 | 8075篇 |
临床医学 | 22176篇 |
内科学 | 30112篇 |
皮肤病学 | 2785篇 |
神经病学 | 12191篇 |
特种医学 | 6321篇 |
外国民族医学 | 12篇 |
外科学 | 25862篇 |
综合类 | 37265篇 |
一般理论 | 24篇 |
预防医学 | 30954篇 |
眼科学 | 2226篇 |
药学 | 26216篇 |
556篇 | |
中国医学 | 29686篇 |
肿瘤学 | 9627篇 |
出版年
2023年 | 4509篇 |
2022年 | 7112篇 |
2021年 | 10865篇 |
2020年 | 12318篇 |
2019年 | 17499篇 |
2018年 | 11447篇 |
2017年 | 10089篇 |
2016年 | 8238篇 |
2015年 | 7654篇 |
2014年 | 15820篇 |
2013年 | 16040篇 |
2012年 | 14190篇 |
2011年 | 15285篇 |
2010年 | 12175篇 |
2009年 | 10565篇 |
2008年 | 9841篇 |
2007年 | 9879篇 |
2006年 | 8374篇 |
2005年 | 7094篇 |
2004年 | 5867篇 |
2003年 | 5197篇 |
2002年 | 4039篇 |
2001年 | 3358篇 |
2000年 | 2940篇 |
1999年 | 2345篇 |
1998年 | 1792篇 |
1997年 | 1631篇 |
1996年 | 1330篇 |
1995年 | 1374篇 |
1994年 | 1262篇 |
1993年 | 1099篇 |
1992年 | 1016篇 |
1991年 | 913篇 |
1990年 | 783篇 |
1989年 | 773篇 |
1988年 | 699篇 |
1987年 | 628篇 |
1985年 | 3065篇 |
1984年 | 4222篇 |
1983年 | 3318篇 |
1982年 | 3210篇 |
1981年 | 2746篇 |
1980年 | 2300篇 |
1979年 | 2049篇 |
1978年 | 1744篇 |
1977年 | 1132篇 |
1976年 | 1680篇 |
1975年 | 1322篇 |
1974年 | 1103篇 |
1973年 | 1062篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
1.
2.
3.
Dikshat Gopal Gupta PhD Neelam Varma MD Praveen Sharma MD Mihai I. Truica MD PhD Sarki A. Abdulkadir MD PhD Parmod Singh PhD Man Updesh Singh Sachdeva MD Shano Naseem MD Mohammad Rizwan Siddiqui PhD Parveen Bose MSc Jogeshwar Binota MSc Pankaj Malhotra MD Alka Khadwal MD Amita Trehan Subhash Varma MD 《Cancer》2023,129(21):3390-3404
4.
Biaoming Xu Yu Chen Mingjing Peng Jin Hai Zheng Chaohui Zuo 《International journal of cancer. Journal international du cancer》2023,152(2):110-122
Pancreatic cancer (PC) is a cancer of the digestive system, and pancreatic ductal adenocarcinoma (PDAC) accounts for approximately 90% of all PC cases. Exosomes derived from PDAC (PDAC-exosomes) promote PDAC development and metastasis. Exosomes are nanoscale vesicles secreted by most cells, which can carry biologically active molecules and mediate communication and cargo transportation among cells. Recent studies have focused on transforming exosomes into good drug delivery systems (DDSs) to improve the clinical treatment of PDAC. This review considers PDAC as the main research object to introduce the role of PDAC-exosomes in PDAC development and metastasis. This review focuses on the following two themes: (a) the great potential of PDAC-exosomes as new diagnostic markers for PDAC, and (b) the transformation of exosomes into potential DDSs. 相似文献
5.
Lorena Martin-Morales Sara Manzano Maria Rodrigo-Faus Adrian Vicente-Barrueco Victor Lorca Gonzalo Núñez-Moreno Paloma Bragado Almudena Porras Trinidad Caldes Pilar Garre Alvaro Gutierrez-Uzquiza 《International journal of cancer. Journal international du cancer》2023,152(2):283-297
Matrix metalloproteinase-11 (MMP11) is an enzyme with proteolytic activity against matrix and nonmatrix proteins. Although most MMPs are secreted as inactive proenzymes and are later activated extracellularly, MMP11 is activated intracellularly by furin within the constitutive secretory pathway. It is a key factor in physiological tissue remodeling and its alteration may play an important role in the progression of epithelial malignancies and other diseases. TCGA colon and colorectal adenocarcinoma data showed that upregulation of MMP11 expression correlates with tumorigenesis and malignancy. Here, we provide evidence that a germline variant in the MMP11 gene (NM_005940: c.232C>T; p.(Pro78Ser)), identified by whole exome sequencing, can increase the tumorigenic properties of colorectal cancer (CRC) cells. P78S is located in the prodomain region, which is responsible for blocking MMP11's protease activity. This variant was detected in the proband and all the cancer-affected family members analyzed, while it was not detected in healthy relatives. In silico analyses predict that P78S could have an impact on the activation of the enzyme. Furthermore, our in vitro analyses show that the expression of P78S in HCT116 cells increases tumor cell invasion and proliferation. In summary, our results show that this variant could modify the structure of the MMP11 prodomain, producing a premature or uncontrolled activation of the enzyme that may contribute to an early CRC onset in these patients. The study of this gene in other CRC cases will provide further information about its role in CRC development, which might improve patient treatment in the future. 相似文献
6.
Danka Cholujova Gabor Beke Zachary R. Hunter Teru Hideshima Ludmila Flores Tatiana Zeleznikova Denisa Harrachova Lubos Klucar Merav Leiba Lubos Drgona Steven P. Treon Efstathios Kastritis David M. Dorfman Kenneth C. Anderson Jana Jakubikova 《International journal of cancer. Journal international du cancer》2023,152(9):1947-1963
Waldenström macroglobulinemia (WM) is a rare subtype of non-Hodgkin lymphoma characterized by malignant lymphoplasmacytic cells in the bone marrow (BM). To dissect the pathophysiology of WM, we evaluated clonal cells by mapping of B cell lymphomagenesis with adaptive and innate immune tumor microenvironment (TME) in the BM of WM patients using mass cytometry (CyTOF). In-depth immunophenotypic profiling of WM cells exhibited profound expansion of clonal cells in both unswitched and switched memory B cells and also plasma cells with aberrant expression variations. WM B lymphomagenesis was associated with reduction of most B cell precursors assessed with the same clonally restricted light chain and phenotypic changes. The immune TME was infiltrated by mature monocytes, neutrophils and adaptive T cells, preferentially subsets of effector T helper, effector CTL and effector memory CTL cells that were associated with superior overall survival (OS), in contrast to progenitors of T cells and myeloid/monocytic lineage subsets that were suppressed in WM cohort. Moreover, decrease in immature B and NKT cells was related to worse OS in WM patients. Innate and adaptive immune subsets of WM TME were modulated by immune checkpoints, including PD-1/PD-L1&PD-L2, TIGIT/PVR, CD137/CD137-L, CTLA-4, BTLA and KIR expression. The response of ibrutinib treatment to the reduction of clonal memory B cell was associated with high levels of immature B cells and effector memory CTL cells. Our study demonstrates that CyTOF technology is a powerful approach for characterizing the pathophysiology of WM at various stages, predicting patient risk and monitoring the effectiveness of treatment strategies. 相似文献
7.
Xiaoke Zhu Yu Heng Jian Zhou Hanqing Lin Liang Zhou Ming Zhang Pengyu Cao Lei Tao 《International journal of cancer. Journal international du cancer》2023,153(1):94-102
A high risk of developing second primary malignancy (SPM) has been reported among head and neck cancer patients. Here, we aimed to statistically quantify the impact of SPM development on the survival of head and neck cancer patients. Our study was conducted using the Surveillance, Epidemiology and End Results database to collect the data of 48 316 patients who received curative surgical resection for initial primary head and neck squamous cell carcinoma (IP-HNSCC) in 1975 to 2019. SPM diagnosis was treated as a time-varying covariate and multivariable Cox regression analysis was conducted to estimate the association between SPM development and survival, overall or by the subsite of IP-HNSCC. Of the included patients, 11 238 patients (23.3%) developed SPM during the follow-up period. A significant reduction in survival was observed among patients with SPM (hazard ratio [HR] for overall survival, 3.30; 95% confidence interval [CI]: 3.20-3.41). The impact of SPM development on reduced survival was more significant in patients with localized IP-HNSCC vs regional IP-HNSCC (HROS, 3.41; 95% CI: 3.24-3.6 vs HROS, 3.18; 95% CI: 3.05-3.31; P for interaction <.001). The survival impact of SPM development was more evident in younger patients than in older patients. SPM in lung and bronchus was associated with the most pronounced reduction in survival, overall and across all subsites of HNSCC. Our results indicated that SPM development led to a significant reduction in survival. A greater survival benefit may be achieved through intensive surveillance for SPM in lung and bronchus targeting younger patients and those with localized HNSCC. 相似文献
8.
Alan G. Nyitray Jenna Nitkowski Timothy L. McAuliffe Bridgett Brzezinski Michael D. Swartz María E. Fernandez Ashish A. Deshmukh Timothy J. Ridolfi Sarah J. Lundeen Leslie Cockerham Dave Wenten Andrew Petroll Brian Hilgeman Jennifer S. Smith Elizabeth Y. Chiao Anna R. Giuliano Vanessa Schick The Prevent Anal Cancer Self-Swab Study Team 《International journal of cancer. Journal international du cancer》2023,153(4):843-853
Sexual minority men are at increased risk for anal squamous cell carcinoma. Our objective was to compare screening engagement among individuals randomized to self-collect an anal canal specimen at home or to attend a clinic appointment. Specimen adequacy was then assessed for human papillomavirus (HPV) DNA genotyping. A randomized trial recruited cisgendered sexual minority men and transgender people in the community and assigned them to use a home-based self-collection swabbing kit or attend a clinic-based swabbing. Swabs were sent for HPV genotyping. The proportions of participants completing screening in each study arm and the adequacy of their specimens for HPV genotyping were assessed. Relative risks were estimated for factors associated with screening. A total of 240 individuals were randomized. Age (median, 46 years) and HIV status (27.1% living with HIV) did not differ by study arm. A total of 89.2% and 74.2% of home-arm and clinic-arm individuals returned the swab, respectively (P = .003), difference between groups, 15.0% (95% CI 5.4%-24.6%). Among black individuals, 96.2% and 63.2% in the home and clinic arms screened (P = .006). Among individuals with HIV, 89.5% and 51.9% in the home and clinic arms screened (P < .001). Self-collected swabs and clinician-collected swabs were comparable in adequacy for HPV genotyping (96.3% and 93.3%, respectively). People at highest risk for anal cancer may be more likely to screen if they are able to self-collect swabs at home rather than attend a clinic. 相似文献
9.
10.
Eileen M. Dryden PhD Meaghan A. Kennedy MD MPH Jennifer Conti MPH Jacqueline H. Boudreau MPH Chitra P. Anwar MA Kathryn Nearing PhD MA Camilla B. Pimentel PhD MPH William W. Hung MD MPH Lauren R. Moo MD 《Health services research》2023,58(Z1):26-35